SYDNEY, AUSTRALIA: Cochlear Limited, a global leader in implantable hearing solutions, today announced the completion of its acquisition of the Oticon Medical cochlear implant business from Demant, with all required conditionality satisfied. Following Demant’s decision to discontinue its efforts in hearing implants, Cochlear has acquired Demant’s cochlear implant business for a zero headline purchase price….
Cochlear Limited (ASX: COH) is a medical device company that designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1981 with finance from the Australian government to commercialise the implants pioneered by Dr Graeme Clark. Today, the company holds…
SYDNEY: Cochlear Limited announced the appointment of Christine McLoughlin to the Cochlear Board. Ms McLoughlin’s appointment will become effective on 1 November 2020.Ms McLoughlin has served on the boards of a number of ASX50 companies and is a highly respected company director with domestic and international experience in financial and health services and telecommunications. Cochlear…